[Corrigendum] Network pharmacology combined with experimental validation to investigate the effect of Rongjin Niantong Fang on chondrocyte apoptosis in knee osteoarthritis
Jun Chen, Ting Zhang, Qingqing Luo, Ruyi Wang, Yuting Dai, Zhenyuan Chen, Chutian Zhang, Xuzheng Chen, Guangwen Wu
Abstract
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Click any figure to enlarge with its caption.
Figure 1
Figure 2
Figure 3
Figure 4Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsHealthcare and Venom Research · Traditional Chinese Medicine Analysis · Pharmacological Effects of Natural Compounds
Mol Med Rep 29: 102, 2024; DOI: 10.3892/mmr.2024.13226
Following the publication of the above article, the authors have drawn to the Editor's attention that a number of corrections are required to four figures featured in the above article, and a textual change is also required in the Results section. Concerning the textual change, in the last sentence of the first paragraph of the Results on p. 4, “…Schischk and 11 for Angelica sinensis (Oliv) Diels”, should have read as: “…Schischk and 10 for Angelica sinensis (Oliv) Diels”, as shown correctly in Fig. 1C on p. 5.
Secondly, concerning the flow cytometric (FCM) data shown in the right-hand flow chart in the second row of Fig. 5E, the authors have realized that these data were inadvertently copied across from the third flow chart in the first row of Fig. 4C. After examining their original data, the authors have realized that the second flow chart in the second row of Fig. 5E was misplaced (showing the results from the “siPARP1+H_2_O_2_” experiment), and the corrected version of this figure is presented in this corrigendum (the corresponding statistical graph shown in Fig. 5F has been replaced as well).
Thirdly, concerning the western blot data shown in Fig. 8 on p. 11, the β-actin internal reference proteins pertaining to the cleaved-caspase-3, PARP1 and cleaved-PARP1 experiments were selected incorrectly for this figure. These data, and the corresponding statistical graphs shown in Fig. 8A-D, have been corrected in the new version of Fig. 8 provided in this corrigendum.
Fourthly, the FCM flow charts to represent the “3,200 µg/ml RJNTF” and “PJ34 inhibitor group” experiments in Fig. 9C on p. 12 were wrongly placed, and both these data and the corresponding statistical graphs have also been corrected in the revised version of Fig. 9 included in this corrigendum.
Finally, in Fig. 10 on p. 13, “” in [Fig. 10D](#f10-mmr-32-2-13581) (relating to the statistical analysis of the data) should have been written as “ns”, and in the corresponding figure legend, “^^P<0.05 vs. RJNTF group” should have been written as “^ns^P<0.05 vs. 1,600 µg/ml RJNTF group”. These corrections have been attended to in the revised version of Fig. 10 provided in this corrigendum.
All the authors approve of the publication of this corrigendum, and the authors are grateful to the Editor of Molecular Medicine Reports for granting them the opportunity to publish this. The authors regret that these errors were included in the paper, and also apologize to the readership for any inconvenience caused.